A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)
Clinical trial NCT02959892 · COMPLETED
Trial details
- NCT number
- NCT02959892
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2017-05-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.